001540 — AHN-GOOK PHARMACEUTICAL Co Balance Sheet
0.000.00%
- KR₩76bn
- KR₩123bn
- KR₩271bn
- 53
- 89
- 18
- 56
Annual balance sheet for AHN-GOOK PHARMACEUTICAL Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS/A | ARS/A | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | — | — | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 48,592 | 46,209 | 36,092 | 35,446 | 29,738 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 37,893 | 44,159 | 55,597 | 62,753 | 59,015 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 111,432 | 116,285 | 122,010 | 135,416 | 134,772 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 70,554 | 70,911 | 70,771 | 73,036 | 120,069 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 206,984 | 219,956 | 223,912 | 238,598 | 302,535 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 44,678 | 52,212 | 61,498 | 78,242 | 77,059 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 57,603 | 66,535 | 69,115 | 86,511 | 136,860 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 149,380 | 153,421 | 154,798 | 152,086 | 165,676 |
Total Liabilities & Shareholders' Equity | 206,984 | 219,956 | 223,912 | 238,598 | 302,535 |
Total Common Shares Outstanding |